Clinical Study

Changes and Diurnal Variation of Visual Quality after Orthokeratology in Myopic Children

Table 5

Effects of orthokeratology on corneal aberrations (, mean ± SD).

TimeComaTrefoilTetrafoilSphS3S4S5S6S7S8

3 mm optical zone
Baseline AM0.048 ± 0.020.143 ± 0.050.105 ± 0.050.009 ± 0.010.155 ± 0.050.140 ± 0.050.091 ± 0.030.102 ± 0.030.063 ± 0.020.071 ± 0.02
1 month AM0.120 ± 0.090.210 ± 0.140.171 ± 0.100.026 ± 0.030.251 ± 0.160.243 ± 0.160.162 ± 0.100.184 ± 0.120.104 ± 0.060.129 ± 0.09
1 month PM0.109 ± 0.110.202 ± 0.140.170 ± 0.090.027 ± 0.020.242 ± 0.170.235 ± 0.150.149 ± 0.100.176 ± 0.120.097 ± 0.070.123 ± 0.09
P10.0020.0470.0110.0030.0150.0050.0050.0030.010.004
P20.6630.8360.9460.9240.8250.810.6160.770.6660.761

4 mm optical zone
Baseline AM0.121 ± 0.050.452 ± 0.210.310 ± 0.110.038 ± 0.020.482 ± 0.190.413 ± 0.120.335 ± 0.110.314 ± 0.090.278 ± 0.120.221 ± 0.06
1 month AM0.534 ± 0.390.673 ± 0.420.604 ± 0.350.198 ± 0.170.903 ± 0.530.820 ± 0.460.657 ± 0.320.641 ± 0.350.468 ± 0.260.440 ± 0.24
1 month PM0.409 ± 0.400.561 ± 0.310.494 ± 0.340.200 ± 0.100.733 ± 0.490.696 ± 0.430.555 ± 0.300.533 ± 0.380.365 ± 0.250.357 ± 0.21
P1<0.0010.036<0.001<0.0010.002<0.001<0.001<0.0010.004<0.001
P20.0560.1920.1810.9230.1010.2370.120.1920.0550.149

5 mm optical zone
Baseline AM0.411 ± 0.370.439 ± 0.390.330 ± 0.320.099 ± 0.150.668 ± 0.460.490 ± 0.450.645 ± 0.450.366 ± 0.300.497 ± 0.270.253 ± 0.20
1 month AM1.016 ± 0.421.175 ± 0.660.858 ± 0.530.451 ± 0.331.644 ± 0.621.454 ± 0.671.412 ± 0.691.266 ± 0.841.205 ± 0.831.042 ± 0.59
1 month PM1.231 ± 1.390.956 ± 1.120.738 ± 0.710.408 ± 0.371.629 ± 1.771.388 ± 1.381.182 ± 1.280.993 ± 0.990.918 ± 0.920.823 ± 0.89
P1<0.001<0.001<0.001<0.001<0.001<0.001<0.001<0.0010.001<0.001
P20.4740.4430.5280.6360.9710.8440.4850.3460.2960.292

Paired t-test. P1: comparison between AM baseline and AM 1 month after orthokeratology; P2: comparison between AM and PM during the same day 1 month after orthokeratology.